GLP-1 Drugs Show Promise Against Obesity-Linked Leukemia
New research suggests that GLP-1 receptor agonists, commonly prescribed for diabetes and weight loss, could be pivotal in a novel dual therapy to combat leukemia exacerbated by obesity.
Category
Search Results for
Latest stories, in-depth analysis & breaking updates
1+
Articles
